Announcement on Receipt of SSE’s "Decision to Terminate the Review of the Private Placement Stock Issuance Application by BrightGene Bio-Medical Technology Co., Ltd."

About this update from Brightgene Bio-medical Technology Co. Ltd. Class A

Announcement on Receipt of SSE’s "Decision to Terminate the Review of the Private Placement Stock Issuance Application by BrightGene Bio-Medical Technology Co., Ltd."The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Brightgene Bio-medical Technology Co. Ltd. Class A